Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Post by EquityInveston Jan 17, 2019 8:37pm
96 Views
Post# 29249024

Common sense dictates....

Common sense dictates....that APHA is currently the most undervalued LP in the sector and that this is not lost to big conglomerates interested in this sector.  The financial fundamentals are the same, the Company continues to grow its business (both domestic and international), change-management is ongoing, short attacks have abated (except for opportunistic law firms taking advantage of downtrodden shareholders), no SEC nor IIROC investigation, etc.

Sure the Company could and should have been more forthcoming and aggressive in defending against the short attacks but we just don't know the extent and comprehensiveness of the forthcoming rebuttal...not yet and I really believe that its release is imminent.

For now holding on to your shares, and even adding to it, makes a lot more sense than letting the bashers on this Board influence you into selling at this ridiculously low price.

APHA's time will come and the shareholders will be handsomely rewarded.  We just need to be patient.

Just my opinion.  Best of luck to all!
EI
Bullboard Posts